greeksoup/ stock research

Labcorp Holdings (LH) FY2024 results: revenue $13.0 billion, up 7.0% on the year

Labcorp Holdings Inc. (LH) reported revenue of $13.0 billion for fiscal 2024, the year ended 31 December 2024, up 7.0% on the year before. Net income was $746 million, up 78.5%, and diluted earnings per share $8.84. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2025.

Revenue
$13.0 billion
+7.0% on the year
FY2017FY2024
Operating margin
8.4%
6.0% a year earlier
FY2017FY2024
Net income
$746 million
+78.5% on the year
FY2017FY2024
Diluted EPS
$8.84
+85.3% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue13,00912,16211,864+7.0%
Cost of revenue9,3848,7978,155+6.7%
Gross profit3,6243,3653,709+7.7%
Gross margin27.9%27.7%31.3%
Selling, general and administrative2,2302,0211,763+10.3%
Operating income1,0877261,436+49.8%
Operating margin8.4%6.0%12.1%
Interest expense208200180+4.4%
Income tax212188234+12.7%
Net income7464181,279+78.5%
Net margin5.7%3.4%10.8%
Diluted EPS$8.84$4.77$13.97+85.3%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow1,5861,3281,956+19.4%
Capital expenditure490454429+8.0%
Free cash flow1,0968741,527+25.4%
Free cash flow margin8.4%7.2%12.9%
Cash from investing-1,367-1,172-1,652
Cash from financing780-59.3-1,322
Depreciation and amortisation644577537+11.5%
Share-based compensation117129117-9.3%
Buybacks2501,0001,100-75.0%
Dividends paid243254195-4.3%
Dividend per share$2.88$2.88$2.160.0%
Diluted shares, weighted84m88m92m-3.7%
Shares outstanding at period end83m84m88m-0.6%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity8,0527,87510,097+2.3%
Debt6,3325,0545,340+25.3%
Operating lease liabilities676649653+4.2%
Finance lease liabilities74.378.683.6-5.5%
Other liabilities3,2453,0683,982+5.8%
Total liabilities and equity18,37916,72520,155+9.9%
Fixed assets3,0452,9122,794+4.6%
Goodwill6,3706,1426,124+3.7%
Intangible assets3,4893,3423,124+4.4%
Cash and equivalents1,519537321+182.9%
Receivables1,9441,9131,786+1.6%
Inventory493475471+3.9%
Other assets1,5191,4045,537+8.2%
Total assets18,37916,72520,155+9.9%

10-K for the year ended 31 December 2024, filed 25 February 2025: the filing.